Vol.

No.

January 29, 2021Jan 29, 2021

Free

DOWNLOAD THE PDF

Ed Kim tells us about building a $1 billion City of Hope campus in Orange County

Cover Story

Conversation with The Cancer Letter Free

Ed Kim tells us about building a $1 billion City of Hope campus in Orange County

By Paul Goldberg

In his previous job, in North Carolina, Edward S. Kim helped build a cancer program where there was none.

Free Obituary

Joe Simone, an oncologist, visionary of treatment guidelines, and author of maxims, dies at 85
Here is his book

By Otis W. Brawley and Paul Goldberg

Free

St. Jude colleagues remember Joe Simone

Free Obituary

Simone: A giant of clinical oncology research and a really good guy

By Robert Cook-Deegan

Free Obituary

Simone, the Mudjekeewis, the elder, the statesman of the cancer world

By Cheryl L. Willman

Free Obituary

Simone, oncology polymath and leader

By Robert C. Young

Free Obituary

“When you've seen one cancer center, you've seen one cancer center”

By Donald L. "Skip" Trump and Eric T. Rosenthal

Clinical Free Trials & Tribulations

Tackling racial disparities through novel approaches to engage communities in research

By Hayley S. Thompson

In Brief

Craig Lockhart named chief of hematology and oncology at MUSC

Terence M. Williams named radiation oncology chair at City of Hope

Coalition of cancer organizations urges resumption of cancer screening and treatment during pandemic

Coalition of cancer scientists create global initiative to evaluate genetic mutations

NYU Dentistry receives $3.28M NIH grant for oral cancer pain research

UAMS Winthrop P. Rockefeller Cancer Institute receives $1M to pursue NCI designation

Clinical Roundup

NCCN shares guidance for vaccinating cancer patients against COVID-19

First mammography screening guidelines issued for older survivors of breast cancer

Variation in tax rates and tobacco control measures produces variation in cancer deaths in 152 U.S. metropolitan and micropolitan areas

Older minority cancer patients experience worse surgical outcomes compared to white patients with similar socioeconomic factors

Drugs & Targets

Opdivo + Cabometyx receives FDA approval for advanced renal cell carcinoma

European Commission approves Keytruda as first-line treatment in adult patients with MSI-H or dMMR colorectal cancer

PREVIOUS ISSUE

NEXT ISSUE

Recent Issues

Ed Kim tells us about building a $1 billion City of Hope campus in Orange County

Joe Simone, an oncologist, visionary of treatment guidelines, and author of maxims, dies at 85
Here is his book

St. Jude colleagues remember Joe Simone

Simone: A giant of clinical oncology research and a really good guy

Simone, the Mudjekeewis, the elder, the statesman of the cancer world

Simone, oncology polymath and leader

“When you've seen one cancer center, you've seen one cancer center”

Tackling racial disparities through novel approaches to engage communities in research

In Brief

Craig Lockhart named chief of hematology and oncology at MUSC

Terence M. Williams named radiation oncology chair at City of Hope

Coalition of cancer organizations urges resumption of cancer screening and treatment during pandemic

Coalition of cancer scientists create global initiative to evaluate genetic mutations

NYU Dentistry receives $3.28M NIH grant for oral cancer pain research

UAMS Winthrop P. Rockefeller Cancer Institute receives $1M to pursue NCI designation

Clinical Roundup

NCCN shares guidance for vaccinating cancer patients against COVID-19

First mammography screening guidelines issued for older survivors of breast cancer

Variation in tax rates and tobacco control measures produces variation in cancer deaths in 152 U.S. metropolitan and micropolitan areas

Older minority cancer patients experience worse surgical outcomes compared to white patients with similar socioeconomic factors

Drugs & Targets

Opdivo + Cabometyx receives FDA approval for advanced renal cell carcinoma

European Commission approves Keytruda as first-line treatment in adult patients with MSI-H or dMMR colorectal cancer

Recent Issues

Renew today!

Subscriber content

Never miss an issue!

Login